• Most Popular
  • Most Shared

Neurobiological Technologies gets Memantine royalty of $2.1 mln

Wed Feb 20, 2008 7:18am EST

Feb 20 (Reuters) - Drug development company Neurobiological Technologies Inc NTII.O said it got about $2.1 million in royalty payments on sales of Memantine, a treatment for Alzheimer's disease, for the quarter ended Sept. 30, 2007.

Stocks

Under an exclusive marketing agreement, the company receives quarterly royalty payments on sales of Memantine from Merz Pharmaceuticals GmbH and its marketing partners. (Reporting by Manish Gupta in Bangalore; Editing by Pratish Narayanan)

Stocks


More from Reuters

Photo

Obama says U.S. will pursue plane attackers

KAILUA, Hawaii (Reuters) - A wing of al Qaeda claimed responsibility on Monday for a failed Christmas Day attack on a U.S.-bound passenger plane and President Barack Obama vowed to bring "every element" of U.S. power against those who threaten Americans' safety. | Video

» More Top News
Passengers pass security notices as they approach the departure gates at Gatwick Airport, in southern England December 28, 2009. REUTERS/Luke MacGregor

Travelers met with hassles

The U.S. is stepping up airline security measures following the Christmas bomb scare. Here's what you can expect.  Full Article | Video 

U.S.
Iranian protesters take a policeman away to a safe place after he was beaten by angry protesters during fierce clashes in central Tehran December 27, 2009. Credit: REUTERS/Stringer

Deaths, arrests in Iran

Is Iran's "iron fist of brutality" a new volatile phase aimed at crushing the refomist movement?  Full Article | Video 

World